Executive Level 1 - Woden, Australia - National Health Funding Body

National Health Funding Body
National Health Funding Body
Verified Company
Woden, Australia

1 month ago

Olivia Brown

Posted by:

Olivia Brown

beBee Recruiter
Description

Job Reference Number 23-TAADIV-17313


Classification Executive Level 1


Job Title Assistant Director


Division Technology Assessment and Access Division


Branch Genomics and Health Technology Assessment Policy Branch


Section Drug Utilisation Section


Location Woden, ACT


Status Ongoing


Employment type Full-time & Part-time


Salary Range $111,940 - $127,670


Security Clearance Baseline (Protected, Highly Protected, Restricted, Confidential)***
Contact Officer Name:Judy Gould


Phone:


Anticipated timeline for Recruitment

Milestone
Date(s)
Applications open Wednesday 19 April 2023

Applications close Wednesday 3 May 2023

Application shortlisting Week commencing 15 May 2023

Work sample assessment N/A

Panel assessment of work sample N/A

Interviews Week commencing 12 June 2023

Reference checks Following interviews


Selection report finalisation Week of 26 June 202- Offers and announcements On or after 3 July 2023availability of the Selection Panel Members.


Eligibility

  • To be eligible for employment with the Department of Health and Aged Care applicants
must be an Australian citizen at the time an offer of employment is made

  • An applicant's suitability for employment with Health will also be assessed through a

variety of pre-employment check processes, such as:

  • Satisfactory completion of a criminal history check, and where relevant a
Working with Children and Vulnerable People Check.

  • Completion of a medical declaration and preemployment medical (where
required).

  • Providing evidence of qualifications.

Division Responsibilities
The Technology Assessment and Access Division (TAAD) supports the government and

works with key stakeholders to provide reliable, timely, safe and affordable access to

medicines, devices and other medical technologies and improved choice in health services

to all Australians, including through the Pharmaceutical Benefits Scheme (PBS), Life Saving

Drugs Program, Prostheses List, national blood arrangements and other targeted assistance

programs, and other programs to improve health outcomes for all Australians.


Branch Responsibilities
The Genomics and Health Technology Assessment Policy Branch provides oversight of a

range of policy and programs with a Health Technology Assessment (HTA) focus to facilitate

patient access to cost effective treatments that improve health outcomes. Key


responsibilities include:

  • Providing policy advice to the Minister on the integration of genomic medicine in the
Australian health care system and implementing of policy, programs, legislation to

deliver efficient, effective, ethical and equitable access to genomic medicine.

  • Providing policy advice to the Minister on HTA related matters and developing new
approaches for HTA programs supporting access to health technologies for patients.

  • Supporting the Pharmaceutical Benefits Advisory Committee (PBAC) through the Drug
Utilisation Sub-Committee (DUSC), Post Market Reviews, PBS process improvements,

transparency measures and cost recovery administration functions.

  • Policy and administration of the lifesaving dugs, stoma products, blood programs.
  • Oversight of Australia's National Medicines Policy framework and initiatives to
strengthen the transparency and resilience of the medicines supply chains.


Section Responsibilities
The Drug Utilisation Section manages the secretariat and supports the DUSC and also the

PBAC through its data driven approach to utilisation reviews of PBS listed medicines and

related programs. The reviews provide a mechanism for the utilisation of medicines to be

considered in the current treatment context, including actual versus predicted utilisation,

budget impacts and monitoring of expenditure and patterns of use. This is done to ensure

PBS listings remain consistent with the initial evidence on clinical and cost-effectiveness

accepted by the PBAC at the time the medicine was listed.

The Section also has responsibility for oversight of a number of data development projects

to support its work and to support PBS listings more broadly. Information on DUSC is
- subcommittee.


Role Description
The Drug Utilisation Sub-Committee (DUSC) is looking to fill an EL1 position, within a multi
- disciplinary team, that will be involved in providing support to the DUSC including the
preparation of utilisation reviews of drugs listed on the Pharmaceutical Benefits Scheme
(PBS), preparation of agenda papers and stakeholder management.

These are exciting opportunities to contribute to the understanding of how subsidised drugs
are used and managed in Australia and contribute to management of the PBS.


Please note:
Applicants found suitable through this process will be placed in a merit pool
that may be used to fill similar positions (ongoing or non-ongoing) within the Division and
Department of Health and Aged Care for up to 18 months.

**Key Resp
More jobs from National Health Funding Body
See all jobs of National Health Funding Body